Serum leptin level as an indicator to predict the clinical efficacy of troglitazone in patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 53, Issue 3, 2001, Pages 161-164

  Maruyama, Satoko ^a   Yanagisawa, Keiko ^a   Kanamuro, Reiko ^a   Teno, Shinichi ^a   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Leptin; Troglitazone; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LEPTIN; TROGLITAZONE;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROTEIN BLOOD LEVEL;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHROMANS; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; THIAZOLES; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 0034908723     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(01)00280-7     Document Type: Article

References (12)

1. Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy
2. Baseline factors affecting the efficacy of troglitazone on plasma glucose in Japanese patients with non-insulin resistant diabetes mellitus
3. Hepatic dysfunction associated with troglitazone
4. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
5. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas
6. Efficacy of troglitazone measured by insulin resistance index
7. Positional cloning of the mouse obese gene and its human homologue
8. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
9. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects
10. Effect of troglitazone in insulin-treated patients with type II diabetes mellitus
11. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinadione in zucker diabetic fatty rats and db/db mice
12. Effect of troglitazone on leptin production: Studies in vitro and in human subjects